Rewired proteostasis in KRAS inhibitor resistance

被引：0
|
作者：
Eccleston, Alex
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2023年 / 22卷 / 11期
关键词：
D O I：
10.1038/d41573-023-00155-0
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：871 / 871
页数：1
相关论文
共 50 条
  • [31] A single inhibitor for all KRAS mutations
    Corcoran, Ryan B.
    NATURE CANCER, 2023, 4 (08) : 1060 - 1062
  • [32] Researchers Reveal Another KRAS Inhibitor
    Leslie, Mitch
    CANCER DISCOVERY, 2019, 9 (09) : 1152 - 1152
  • [33] KRAS Inhibitor Continues to Impress in NSCLC
    Caruso, Catherine
    CANCER DISCOVERY, 2020, 10 (11) : 1617 - 1617
  • [34] Mechanisms of acquired resistance to EGFR tyrosine kinase inhibitor osimertinib and KRAS-G12C inhibitor sotorasib in lung cancer
    Yagami, Yuri
    Sato, Takashi
    Yamamoto, Hiroki
    Shirasawa, Masayuki
    Nakahara, Yoshiro
    Hideo, Watanabe
    Katsuhiko, Naoki
    CANCER RESEARCH, 2024, 84 (06)
  • [35] A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer
    Kulkarni, Prakash
    Mohanty, Atish
    Ramisetty, Sravani
    Duvivier, Herbert
    Khan, Ajaz
    Shrestha, Sagun
    Tan, Tingting
    Merla, Amartej
    El-Hajjaoui, Michelle
    Malhotra, Jyoti
    Singhal, Sharad
    Salgia, Ravi
    BIOMOLECULES, 2023, 13 (11)
  • [36] EMT is a cause of both intrinsic and acquired resistance to KRAS G12C inhibitor in KRAS G12C mutant NSCLC
    Adachi, Yuta
    Ito, Kentaro
    Kimura, Ryo
    Yamaguchi, Rui
    Ebi, Hiromichi
    ANNALS OF ONCOLOGY, 2021, 32 : S307 - S307
  • [37] Focal adhesive kinase inhibitor IN10018 sensitizes KRAS mutant cancer and overcomes drug resistance of KRAS G12C inhibition
    Zhang, Baoyuan
    Zhang, Yan
    Zhang, Jiangwei
    Liu, Ping
    Jiao, Bo
    Wang, Zaiqi
    Ren, Ruibao
    CANCER RESEARCH, 2020, 80 (16)
  • [38] Secondary KRAS mutations lead to acquired resistance to KRASG12D inhibitor in colorectal cancer
    Lieb, Simone
    Jurado, Sabine
    Nowoshilow, Serge
    Zak, Krzysztof M.
    Hofmann, Marco H.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [39] The KRAS-G12C inhibitor: activity and resistance (vol 29, pg 875, 2021)
    Liu, Jiao
    Kang, Rui
    Tang, Daolin
    CANCER GENE THERAPY, 2024, 31 (01) : 18 - 27
  • [40] Persisting RAS addiction: A therapeutic vulnerability in the context of KRAS G12C inhibitor resistance
    Morrissey, G. J.
    McDaid, W.
    Simpson, K.
    Carter, M.
    Chaturvedi, A.
    Lindsay, C. R.
    Malliri, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1160 - S1160
12345